Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Viral exposures and MS outcome in a prospective cohort of children with acquired demyelination.
Charcot-Marie-Tooth disease: Frequency of genetic subtypes in a German neuromuscular center population.
Serum nicotinamide adenine dinucleotide levels through disease course in multiple sclerosis.
Which is the goal of cognitive rehabilitation in multiple sclerosis: the improvement of cognitive performance or the perception of cognitive deficits?
BG-12 in Multiple Sclerosis.
Concomitant analysis of arterial, venous, and CSF flows using phase-contrast MRI: a quantitative comparison between MS patients and healthy controls.
A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing-remitting multiple sclerosis.
Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla.
Secondary progression and innate immunity in NMO: A possible link to alemtuzumab therapy?
Biomarkers of interferon Beta therapy in multiple sclerosis.
Bhlhe40 controls cytokine production by T cells and is essential for pathogenicity in autoimmune neuroinflammation.
A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis.
Chronic Voluntary Ethanol Consumption Induces Favorable Ceramide Profiles in Selectively Bred Alcohol-Preferring (P) Rats.
Technical developments of functional electrical stimulation to correct drop foot: Sensing, actuation and control strategies.
PERK-opathies: an endoplasmic reticulum stress mechanism underlying neurodegeneration.
Electrodiagnostic evaluation of peripheral nervous system changes in patients with multiple sclerosis.
miR-20b Suppresses Th17 Differentiation and the Pathogenesis of Experimental Autoimmune Encephalomyelitis by Targeting RORγt and STAT3.
Immunogenicity and other problems associated with the use of biopharmaceuticals.
Dalfampridine: review of its efficacy in improving gait in patients with multiple sclerosis.
Interferon-beta or azathioprine as add-on therapies in patients with active multiple sclerosis.
Is environmental radon gas associated with the incidence of neurodegenerative conditions? A retrospective study of multiple sclerosis in radon affected areas in England and Wales.
Reproducibility of T2 * mapping in the human cerebral cortex in vivo at 7 tesla MRI.
Astrocyte response to IFN-γ limits IL-6-mediated microglia activation and progressive autoimmune encephalomyelitis.
Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group.
Role of microRNAs in the regulation of innate immune cells under neuroinflammatory conditions.
Pages
« first
‹ previous
…
453
454
455
456
457
458
459
460
461
…
next ›
last »